Biovian
Turku, Finland
Compare AAV CDMOs in Europe
Compare Lentiviral CDMOs in Europe
Compare Recombinant Proteins CDMOs in Europe
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-02
79.4
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
✓ HC GMP (5)
Quick Facts: Biovian
- Signal Score
- 79.4/100 (as of 2026-11-02)
- Quality Compliance
- 99.8/100 — Clean EMA record: 4 active GMP certificates (no deductions)
- Headquarters
- Turku, Finland
- Modalities
- AAV, Lentiviral, Microbial Fermentation, Recombinant Protein
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Biovian
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.8
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-12-19)
EMA GMP Certificates4 on record
Most Recent HC OutcomeCompliant · 2024-12-19
HC Attribution5 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 4 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Microbial Fermentation, Recombinant Protein
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
Broad modality coverage (4 modalities)
Sites: Turku, FI
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Broad modality coverage (4 modalities)
Biovian FDA Inspection History
2024-12
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2024-12-19 |
Biovian Oy
Turku
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Biovian EMA GMP Compliance 4 certificates
2026-03
2024-12
2024-12
2024-12
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| FIMEA/2026/001005 laboratory | Biovian Oy | Finland | 2026-03-18 | COMPLIANT |
| FIMEA/2024/006346 laboratory | Biovian Oy | Finland | 2024-12-19 | COMPLIANT |
| FIMEA/2024/006346 IMP | Biovian Oy | Finland | 2024-12-19 | COMPLIANT |
| FIMEA/2024/006346 | Biovian Oy | Finland | 2024-12-19 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity 2 open roles Beta
From public job postings on Biovian's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
2
open roles
2
in manufacturing, quality, PD/MSAT, engineering or regulatory (100%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 0 taken down.
By function
By site
Turku, Varsinais-Suomi, Finland
profile site
1 mfg/ops · 1 PD/MSAT 2
1 mfg/ops · 1 PD/MSAT 2
Latest postings
Scientist, DSP
Process development & MSAT · Turku, Varsinais-Suomi, Finland · posted Nov 16, 2026
Bioprocess technician
Manufacturing & operations · Turku, Varsinais-Suomi, Finland · posted Nov 10, 2026
Coverage: counted from Biovian's own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
biovian.recruitee.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About Biovian
How many FDA inspections does Biovian have on record?
CDMO Signal tracks 1 FDA inspection for Biovian, sourced from the FDA inspection database. See the full inspection history above.
Has Biovian received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Biovian.
Does Biovian hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Biovian.
What is Biovian's CDMO Signal Score?
Biovian has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating Biovian for a manufacturing program?
Use the free AI matchmaker to compare Biovian against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Compare Biovian with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.